Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Cotter

Showing results (131-140 of 290) with videos related to

Pageof 29
Sort By:
ESC Heart Failure|September 25, 2025
Simultaneous vaccination against influenza and respiratory syncytial virus in high-risk heart failure patientsJan Biegus, Leszek Szenborn, Michał Tkaczyszyn, et al.
Cardiovascular Diagnosis and Therapy|September 16, 2021
Differences in socio-demographic and risk factor profile, clinical presentation, and outcomes between patients with and without RHD heart failure in Sub-Saharan Africa: results from the THESUS-HF registryClovis Nkoke, Albertino Damasceno, Christopher Edwards, et al.
European Journal of Heart Failure|August 11, 2004
The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failureGad Cotter, Edo Kaluski, Karl Stangl, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 14, 2016
Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF studySven Meyer, John R Teerlink, Marco Metra, et al.
American Heart Journal|February 7, 2012
Design of the RELAXin in acute heart failure studyPiotr Ponikowski, Marco Metra, John R Teerlink, et al.
ESC Heart Failure|October 1, 2019
Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trialJan Biegus, Biniyam Demissei, Douwe Postmus, et al.
Cardiology|November 20, 2010
Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF studyOlga Milo-Cotter, John R Teerlink, Marco Metra, et al.
European Journal of Heart Failure|June 26, 2014
Renal dysfunction in African patients with acute heart failureMahmoud U Sani, Beth A Davison, Gad Cotter, et al.
Cardiology|October 1, 2010
Acute heart failure clinical drug development: from planning to proof of activity to phase IIIGad Cotter, Adriaan A Voors, Beth Davison Weatherley, et al.
European Journal of Heart Failure|October 8, 2014
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHFAdriaan A Voors, Beth A Davison, John R Teerlink, et al.
Pageof 29

Showing results (131-140 of 290) with videos related to

Sort By:
Pageof 29
ESC Heart Failure|September 25, 2025
Simultaneous vaccination against influenza and respiratory syncytial virus in high-risk heart failure patientsJan Biegus, Leszek Szenborn, Michał Tkaczyszyn, et al.
Cardiovascular Diagnosis and Therapy|September 16, 2021
Differences in socio-demographic and risk factor profile, clinical presentation, and outcomes between patients with and without RHD heart failure in Sub-Saharan Africa: results from the THESUS-HF registryClovis Nkoke, Albertino Damasceno, Christopher Edwards, et al.
European Journal of Heart Failure|August 11, 2004
The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failureGad Cotter, Edo Kaluski, Karl Stangl, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 14, 2016
Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF studySven Meyer, John R Teerlink, Marco Metra, et al.
American Heart Journal|February 7, 2012
Design of the RELAXin in acute heart failure studyPiotr Ponikowski, Marco Metra, John R Teerlink, et al.
ESC Heart Failure|October 1, 2019
Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trialJan Biegus, Biniyam Demissei, Douwe Postmus, et al.
Cardiology|November 20, 2010
Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF studyOlga Milo-Cotter, John R Teerlink, Marco Metra, et al.
European Journal of Heart Failure|June 26, 2014
Renal dysfunction in African patients with acute heart failureMahmoud U Sani, Beth A Davison, Gad Cotter, et al.
Cardiology|October 1, 2010
Acute heart failure clinical drug development: from planning to proof of activity to phase IIIGad Cotter, Adriaan A Voors, Beth Davison Weatherley, et al.
European Journal of Heart Failure|October 8, 2014
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHFAdriaan A Voors, Beth A Davison, John R Teerlink, et al.
Pageof 29